Stock Report

All about this stock under one free report Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Emmessar Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524768

₹23.77

up-down-arrow ₹-0.53 (-2.18%)

As on 04-Sep-2026IST

Market cap

info icon

₹12 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

30.3

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -36.56 -36.56 -46.08 -27.35 -45.04
EBIT 4.33 -24.50 -44.89 -33.20 -218.06
Net Profit 282.35 -23.98 -2.00 2.78 -23.62
EPS 282.09 -23.98 -1.99 2.79 -23.62
Book Value -- -- 4.13 7.71 12.58
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -153.49-143.89-454.01-171.48-212.21
Net Margin info 19.9019.5316.4812.0729.43
Return on equity info 7.5611.964.874.1910.66
Return on Capital info 13.0120.01--12.6311.42
Return on Assets info 6.269.514.183.488.89
Debt to Equity (x) info ----0.000.000.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
12.63
11.42
14.99
15.71
Peer Median
--
21.76
21.89
--
17.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

4.87

Lower than Peers by 10.48

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.87
4.19
10.66
7.85
8.01
Peer Median
15.35
17.93
16.42
--
17.35
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

4.18

Lower than Peers by 6.17

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.18
3.48
8.89
6.42
6.30
Peer Median
10.35
12.81
12.32
--
10.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-454.01

Lower than Peers by 472.01

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-454.01
-171.48
-212.21
-76.78
-270.27
Peer Median
18.01
18.93
21.05
--
11.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

16.48

Higher than Peers by 2.03

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
16.48
12.07
29.43
18.19
20.82
Peer Median
14.45
14.94
15.51
--
11.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
0.00
67.74
152.59
58.61
155.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-46.08

Lower than Peers by 58.03

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-46.08
10.03
-45.53
179.31
-94.78
Peer Median
11.95
10.90
13.44
--
11.49
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-44.89

Lower than Peers by 66.48

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-44.89
11.08
-50.57
20.66
-224.77
Peer Median
21.60
15.01
23.50
--
-1.10
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-2.00

Lower than Peers by 24.73

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-2.00
-57.82
48.79
5.97
-67.21
Peer Median
22.73
14.80
30.12
--
4.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-1.99

Lower than Peers by 22.02

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-1.99
-57.82
48.79
5.98
-67.21
Peer Median
20.03
14.27
29.02
--
10.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
4.13
11.07
8.03
8.21
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
0.01
0.01
--
Peer Median
0.00
0.06
0.03
--
0.18
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
0.01
0.01
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

20.28

Higher than Peers by 18.20

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
20.28
11.34
12.95
10.70
5.58
Peer Median
2.08
1.90
2.23
--
1.72
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

20.03

Higher than Peers by 18.49

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
20.03
11.16
12.78
10.46
5.51
Peer Median
1.54
1.46
1.59
--
1.41
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

127.75

Higher than Peers by 108.37

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
127.75
331.41
626.08
744.77
932.50
Peer Median
19.38
24.96
45.29
--
24.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

4.75

Lower than Peers by 16.63

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.75
2.91
4.02
1.06
3.54
Peer Median
21.38
21.77
20.10
--
23.77
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.04

Lower than Peers by 0.68

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
0.04
0.07
0.07
0.13
0.05
Peer Median
0.72
0.76
0.81
--
1.05
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
11.98
10.88
4.24
1,361.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
63.60
74.06
36.60
67.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
12.45
16.76
--
752.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
63.13
68.18
--
677.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

30.30

Lower than Peers by 4.64

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
30.30
48.02
19.81
24.59
28.90
Peer Median
34.93
26.81
39.85
--
26.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.44

Lower than Peers by 3.83

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
1.44
1.97
2.01
1.86
2.23
Peer Median
5.27
4.65
6.11
--
3.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
--
--
--
Peer Median
0.31
0.61
0.37
--
0.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

7.49

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
7.49
7.85
9.63
6.86
8.93
Peer Median
--
27.02
34.57
--
17.31
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

12

Lower than Peers by 21,095

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
12
15
15
12
14
Peer Median
21,107
20,914
25,297
--
474
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...